These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 10617533)
21. Management of asthma in children. Townshend J; Hails S; McKean M BMJ; 2007 Aug; 335(7613):253-7. PubMed ID: 17673768 [No Abstract] [Full Text] [Related]
22. Clinical Decisions. Treatment of mild persistent asthma. Kraft M; Israel E; O'Connor GT N Engl J Med; 2007 May; 356(20):2096-100. PubMed ID: 17507711 [No Abstract] [Full Text] [Related]
23. Safety Study of Salmeterol in Asthma in Adults. Stempel DA; Yeakey AM; Pascoe SJ N Engl J Med; 2016 Sep; 375(11):1098. PubMed ID: 27626531 [No Abstract] [Full Text] [Related]
24. Safety Study of Salmeterol in Asthma in Adults. Wilsdon T; Kichenadasse G; Rowland A N Engl J Med; 2016 Sep; 375(11):1096-7. PubMed ID: 27626532 [No Abstract] [Full Text] [Related]
25. Safety Study of Salmeterol in Asthma in Adults. Hasegawa T; Uno H; Wei LJ N Engl J Med; 2016 Sep; 375(11):1097. PubMed ID: 27626533 [No Abstract] [Full Text] [Related]
26. Safety Study of Salmeterol in Asthma in Adults. Weinberger M N Engl J Med; 2016 Sep; 375(11):1097-8. PubMed ID: 27626534 [No Abstract] [Full Text] [Related]
29. Cessation of long-acting β2-agonist in children with persistent asthma on inhaled corticosteroids. Ducharme FM; Gagnon R; Bénard B; Tse SM; Thivierge R Eur Respir J; 2016 Aug; 48(2):558-60. PubMed ID: 27230440 [No Abstract] [Full Text] [Related]
30. [Limitations of current treatment of asthma: possibilities for new treatment forms]. Wilkens H; Sybrecht GW Med Klin (Munich); 1996 May; 91(5):302-7. PubMed ID: 8709908 [No Abstract] [Full Text] [Related]
31. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma']. Diamant Z; Dekhuijzen PN Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539 [TBL] [Abstract][Full Text] [Related]
32. [Non-interventional study with remarkable results. Improved asthma control and quality of life with montelukast]. MMW Fortschr Med; 2009 May; 151(21):40-1. PubMed ID: 19537636 [No Abstract] [Full Text] [Related]
33. Pragmatic trials--guides to better patient care? Ware JH; Hamel MB N Engl J Med; 2011 May; 364(18):1685-7. PubMed ID: 21542739 [No Abstract] [Full Text] [Related]
34. Inhaled steroids and the risk of hospitalization for asthma. Donahue JG; Weiss ST; Livingston JM; Goetsch MA; Greineder DK; Platt R JAMA; 1997 Mar; 277(11):887-91. PubMed ID: 9062326 [TBL] [Abstract][Full Text] [Related]
35. The use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta McKibben S; Bush A; Thomas M; Griffiths C NPJ Prim Care Respir Med; 2017 Apr; 27(1):30. PubMed ID: 28446776 [No Abstract] [Full Text] [Related]
36. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409 [TBL] [Abstract][Full Text] [Related]
37. Angiopoietin 1 and 2 levels in inhaled steroid using children with stable asthma. Koksal B; Ozbek OY Ann Allergy Asthma Immunol; 2016 Oct; 117(4):448. PubMed ID: 27742088 [No Abstract] [Full Text] [Related]
38. Genetics and the variability of treatment response in asthma. Israel E J Allergy Clin Immunol; 2005 Apr; 115(4 Suppl):S532-8. PubMed ID: 15806036 [TBL] [Abstract][Full Text] [Related]